Pharma Mar | PHM - Stammkapital

Aktienkurs
79.90
Täglich Wechseln
1.15 1.46%
Monatlich
2.70%
Jährlich
-10.48%
Q1 Prognose
76.50




Stammkapital Veränderung Datum
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Almirall EUR 214.79M 0 2025-12
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Pharma Mar EUR 17.36M 214.99K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09